Earum Pharmaceuticals Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 17.13 million compared to INR 42.79 million a year ago. Revenue was INR 23.72 million compared to INR 51.44 million a year ago.

Net loss was INR 2.8 million compared to net income of INR 3.63 million a year ago.